Aytu Biopharma (AYTU) Current Taxes (2020)
Aytu Biopharma's (AYTU) quarterly Current Taxes came in at $175000.0 in Q2 2020.
Powered by 
Analysis
Aytu Biopharma (AYTU) Current Taxes (2020) Analysis & Trends
Aytu Biopharma (AYTU) has reported Current Taxes for 1 consecutive years, with $175000.0 the latest figure, recorded in Q2 2020.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $175000.0 in Q2 2020; TTM through Jun 2020 was $175000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $175000.0, changed N/A from the prior year.
- Current Taxes was $175000.0 for Q2 2020 at Aytu Biopharma.
- Over five years, Current Taxes peaked at $175000.0 in Q2 2020 and troughed at $175000.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.13 Bn | 625.38 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 442.39 Bn | 435.82 Bn | 12.70 Bn | - |
| 3 | Merck | 366.26 Bn | 359.12 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 266.58 Bn | 258.89 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 159.00 Bn | 147.30 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 8 | Incyte | 25.41 Bn | 20.87 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | - |
| 10 | Aytu Biopharma | 22.49 Mn | -4.22 Mn | 7.60 Mn | - |